Navigation Links
Bluestar Silicones Presents Elastomer Solutions At Medical Design And Manufacturing (MD&M) East Show
Date:6/13/2013

PHILADELPHIA, June 13, 2013 /PRNewswire/ -- Bluestar Silicones will showcase its new Silbione® silicone elastomer solutions, including low durometer liquid silicone rubber (LSR) and self-bleeding LSR, at the upcoming Medical Design & Manufacturing (MD&M) East Conference (Booth #3744), June 18-20.  

Bluestar Silicones' new 1 Shore A (ShA) hardness product, Silbione LSR 4301, uniquely combines strong physical properties and easy processing in a low-durometer material. This product rounds out the company's 5 and 10 ShA soft LSR range, delivering high tear strength and elongation for soft cushioning and vibration dampening applications.

The company also introduces its new Silbione LSR 4755, which creates a lubricious surface on the molded part after vulcanization.  This lubricious material is designed to minimize friction and prevent slit healing in application.  Built into the bulk LSR formulation, the self bleeding lubricity of Silbione LSR 4755 eliminates the need for a secondary coating process to reduce coefficient of friction, reducing costs and improving cycle time for the part manufacturer.

"Bluestar Silicones is excited to present these specialty silicone solutions to the market," according to Karen O'Keefe, market manager, North America.  "The high performance physicals of our low durometer LSRs are unmatched in the industry.  And, our self-bleeding material provides a solution to the inherent non-slip surface of LSRs, improving productivity in automated assembly and part performance in select applications."

These specialty LSR products are manufactured in a clean room environment at Bluestar Silicones' new 226,000-sq-ft facility in York, S.C., and incorporate the distinctive advantages of Bluestar Silicones' standard LSR product line, including easy processing, easy release, and high-performance physical properties.

Bluestar Silicones also offers antimicrobial capability for OEMs and processors, which can be incorporated into its standard silicone products, providing a tailored material solution to meet specific healthcare requirements.

In addition to Bluestar Silicones' full line of LSR, the company offers high consistency rubbers (HCR), room-temperature vulcanized silicones (RTVs), skin adhesive tacky gels, cushioning gels and permanent adhesives for the healthcare market.  For more information, call (866) 474-6342.

About Bluestar Silicones

With worldwide operations headquartered in Lyon, France, Bluestar Silicones is a $650 million worldwide silicones raw material manufacturer. The company is one of the world's leading fully integrated global silicones manufacturers with more than 60 years of silicone expertise. Bluestar Silicones has manufacturing operations throughout the world and combines upstream silicon metal operations and capacity with downstream silicone market and application development expertise. The company offers a comprehensive range of silicone technologies in support of diverse specialty markets including paper release, textile coatings, healthcare, moldmaking, automotive, aerospace, and personal care. For more information, call (866) 474-6342.

Press Contact: Karen O'Keefe
Email: Karen.okeefe@bluestarsilicones.com


'/>"/>
SOURCE Bluestar Silicones
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Discovery Labs Presents Final Assessment in a Series of Pharmacoeconomic Analyses that Explore Impact of Reintubation on Healthcare Costs
2. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
3. Molly Fletcher to Speak at Astellas Presents Executive Womens Day at the FedEx St. Jude Classic
4. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
5. NewLink Genetics Presents Results from Two Phase 1 Studies with Immunotherapy Agent, Indoximod, at the ASCO 2013 Annual Meeting
6. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
7. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
8. NewLink Genetics Presents Positive Phase 2 Data on Novel Immunotherapy, Tergenpumatucel-L, in Non-Small Cell Lung Cancer at the ASCO 2013 Annual Meeting
9. Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma
10. BioElectronics Presents FDA Reclassification Panel
11. Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)...  A new survey from the American ... Bidding Program (CBP) significantly reduced beneficiary choice and access ... choice forces beneficiaries to switch to unfamiliar or unsuitable ... AADE,s survey is the latest in a ... out the inherent problems with the CBP. Last year, ...
(Date:3/27/2017)... YORK , March 27, 2017 FinancialBuzz.com News ... According to a new ... North America , grew 34 percent to $6.7 billion and ... rate of (CAGR) over the next five years, from $6.7 billion in ... of Americans that will be able to purchase cannabis without a doctor,s ...
(Date:3/27/2017)... March 27, 2017   Pulmatrix, Inc . (NASDAQ: PULM), ... address serious pulmonary diseases, today announced that it has added ... fibrosis and asthma to its Scientific Advisory Board . ... Richard B. Moss , MD, former chief of the ... Cystic Fibrosis Center at Stanford University, and ...
Breaking Medicine Technology:
(Date:3/28/2017)... Ohio (PRWEB) , ... March 28, 2017 , ... Columbus ... was selected as one of few medical professionals in the country to sit on ... Founder of Juvly Aesthetics, in just 2 years Dr. Harper helped propel the clinic ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon ... and this procedure adds to SkyLex Advanced Surgical’s already comprehensive list of ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... With expansion ... Marshallville, Georgia, in early March. , The seed processing plant opened in Marshallville in ... since 2016. The new office allows opportunity for transition of Patten Seed operations to ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Thank you to ... on February 8-10. , This event was exclusive to providers and offered an ... The meeting took place at the Manchester Grand Hyatt where attendees gathered for a ...
(Date:3/28/2017)... ... 2017 , ... Bacteria and fungi are probably not the first ingredients that come to mind ... right microorganisms in your diet can actually improve health outcomes. And the good news is ... topic of a new peer-reviewed paper led by Maria Marco, Ph.D. , ...
Breaking Medicine News(10 mins):